Purchases and Sales Made in Q2 2021 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q2 2021. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 16, 2021
Q2 2021
|
Endurant Capital Management LP
San Mateo, CA |
BUY
|
- |
161KNew |
$831K - $1.14M
|
161K
$83.6K
|
|
Aug 13, 2021
Q2 2021
|
Old Mission Capital LLC
|
BUY
|
- |
11.3KNew |
$58.5K - $80.4K
|
11.3K
$5.89K
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
SELL
|
- |
-835- 44.13% |
$4.32K - $5.93K
|
1.06K
$550
|
|
Aug 03, 2021
Q2 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-670K- 89.35% |
$3.46M - $4.76M
|
79.9K
$41.5K
|